UTIs in patients with neurogenic bladder

Area of Science:

• Urology
• Infectious Diseases
• Neuroscience

Background:

• Urinary tract infections (UTIs) are a significant cause of morbidity and mortality in spinal cord injury (SCI) patients with neurogenic bladder.
• Classic UTI symptoms are often absent in neurogenic bladder patients, who may present with increased spasticity, autonomic dysreflexia, or incontinence.
• Risk factors for UTIs in this population include urinary stasis, high bladder pressures, bladder stones, and catheter use.

Purpose of the Study:

• To review current prevention and treatment strategies for UTIs in neurogenic bladder patients.
• To highlight the unique challenges and atypical presentations of UTIs in this patient group.
• To assess the efficacy of various UTI prevention modalities.

Main Methods:

• Literature review of studies assessing UTI prevention in neurogenic bladder patients.
• Analysis of risk factors and atypical UTI symptoms in this population.
• Evaluation of different preventative strategies, including catheter management, oral supplements, bladder irrigation, detrusor injections, and prophylactic antimicrobials.

Main Results:

• Several prevention strategies, including E. coli HU2117 bladder inoculation, iAluRil irrigation, detrusor injections, and weekly alternating antibiotics, show potential for UTI reduction.
• These promising methods require further investigation to confirm their efficacy and safety.
• Treatment of symptomatic UTIs necessitates consideration of diverse microbial flora and antibiotic resistance patterns, emphasizing the importance of urine cultures.

Conclusions:

• Effective management of UTIs in neurogenic bladder patients requires understanding atypical symptoms and tailored prevention strategies.
• Further research is crucial to validate novel UTI prevention methods.
• Antibiotic therapy should be guided by urine culture and sensitivity testing to address varied flora and resistance.